The input to this workflow is a data matrix of gene expression that was collected from a pediatric patient tumor patient from the KidsFirst Common Fund program [1]. The RNA-seq samples are the columns of the matrix, and the rows are the raw expression gene count for all human coding genes (Table 1). This data matrix is fed into TargetRanger [2] to screen for targets which are highly expressed in the tumor but lowly expressed across most healthy human tissues based on gene expression data collected from postmortem patients with RNA-seq by the GTEx Common Fund program [3]. Based on this analysis the gene IMP U3 small nucleolar ribonucleoprotein 3 (IMP3) was selected because it was the top candidate returned from the TargetRanger analysis (Tables 2-3). IMP3 is also commonly called insulin-like growth factor 2 mRNA-binding protein 3 (IGF2BP3). Next, we leverage unique knowledge from various other Common Fund programs to examine various functions and knowledge related to IMP3. First, we queried the LINCS L1000 data [4] from the LINCS program [5] converted into RNA-seq-like LINCS L1000 Signatures [6] using the SigCom LINCS API [7] to identify mimicker or reverser small molecules that maximally impact the expression of IMP3 in human cell lines (Fig. 1, Table 4). In addition, we also queried the LINCS L1000 data to identify single gene CRISPR knockouts that down-regulate the expression of IMP3 (Fig. 1, Table 5). These potential drug targets were filtered using the Common Fund IDG program's list of understudied proteins [8] to produce a set of additional targets (Table 6). Next, IMP3 was searched for knowledge provided by the with the Metabolomics Workbench MetGENE tool [9]. MetGENE aggregates knowledge about pathways, reactions, metabolites, and studies from the Metabolomics Workbench Common Fund supported resource [10]. The Metabolomics Workbench was searched to find associated metabolites linked to IMP3 [10]. Furthermore, we leveraged the Linked Data Hub API [11] to list knowledge about regulatory elements associated with IMP3 (Table 6). Finally, the GlyGen database [12] was queried to identify relevant sets of proteins that are the product of the IMP3 genes, as well as known post-translational modifications discovered on IMP3.
- Lonsdale, J. et al. The Genotype-Tissue Expression (GTEx) project. Nature Genetics vol. 45 580–585 (2013). doi:10.1038/ng.2653
- Evangelista, J. E. et al. SigCom LINCS: data and metadata search engine for a million gene expression signatures. Nucleic Acids Research vol. 50 W697–W709 (2022). doi:10.1093/nar/gkac328
- IDG Understudied Proteins, https://druggablegenome.net/AboutIDGProteinList
- MetGENE, https://sc-cfdewebdev.sdsc.edu/MetGENE/metGene.php
- The Metabolomics Workbench, https://www.metabolomicsworkbench.org/
- Linked Data Hub, https://ldh.genome.network/cfde/ldh/
- York, W. S. et al. GlyGen: Computational and Informatics Resources for Glycoscience. Glycobiology vol. 30 72–73 (2019). doi:10.1093/glycob/cwz080
Click and drag the diagram to pan, double click or use the controls to zoom.
Inputs
ID | Name | Description | Type |
---|---|---|---|
step-1-data | Input File | Upload a Data File |
|
step-4-data | Select One Gene | Select one Gene |
|
Steps
ID | Name | Description |
---|---|---|
step-1 | Input File | Upload a Data File |
step-2 | Resolve a Gene Count Matrix from a File | Ensure a file contains a gene count matrix, load it into a standard format |
step-3 | Screen for Targets against GTEx | Identify significantly overexpressed genes when compared to normal tissue in GTEx |
step-4 | Select One Gene | Select one Gene |
step-5 | LINCS L1000 Reverse Search | Identify RNA-seq-like LINCS L1000 Signatures which reverse the expression of the gene. |
step-6 | Extract Down Regulating Perturbagens | Identify RNA-seq-like LINCS L1000 Chemical Perturbagen Signatures which reverse the expression of the gene. |
step-7 | Extract Down Regulating CRISPR KOs | Identify RNA-seq-like LINCS L1000 CRISPR KO Signatures which reverse the expression of the gene. |
step-8 | Filter genes by Understudied Proteins | Based on IDG understudied proteins list |
step-9 | MetGENE Search | Identify gene-centric information from Metabolomics. |
step-10 | MetGENE Metabolites | Extract Metabolomics metabolites for the gene from MetGENE |
step-11 | MetGENE Reactions | Extract Metabolomics reactions for the gene from MetGENE |
step-12 | Resolve Regulatory Elements from LDH | Resolve regulatory elements from gene with Linked Data Hub |
step-13 | Search GlyGen for Protein Products | Find protein product records in GlyGen for the gene |
Outputs
ID | Name | Description | Type |
---|---|---|---|
step-1-output | File URL | URL to a File |
|
step-2-output | Gene Count Matrix | A gene count matrix file |
|
step-3-output | Scored Genes | ZScores of Genes |
|
step-4-output | Gene | Gene Term |
|
step-5-output | LINCS L1000 Reverse Search Dashboard | A dashboard for performing L1000 Reverse Search queries for a given gene |
|
step-6-output | Scored Drugs | ZScores of Drugs |
|
step-7-output | Scored Genes | ZScores of Genes |
|
step-8-output | Scored Genes | ZScores of Genes |
|
step-9-output | MetGENE Summary | A dashboard for reviewing gene-centric information for a given gene from metabolomics |
|
step-10-output | MetGENE metabolite table | MetGENE metabolite table |
|
step-11-output | MetGENE Reaction Table | MetGENE Reaction Table |
|
step-12-output | Regulatory Element Set | Set of Regulatory Elements |
|
step-13-output | GlyGen Protein Products | Protein product records in GlyGen |
|
Version History
Version 1 (earliest) Created 16th Apr 2024 at 22:42 by Daniel Clarke
Initial commit
Open
master
7d7d4ea
Creators
Not specifiedSubmitter
Views: 824 Downloads: 136
Created: 16th Apr 2024 at 22:42
Last updated: 23rd Apr 2024 at 16:54
This item has not yet been tagged.
None